ArticleAlzheimer's & dementia (New York, N. Y.)2017

Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease.

Rania Soudy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.